NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Accenture Sees Shares Rise 4.7% Following Strong Second Quarter Earnings

Accenture (NYSE: ACN) witnessed a 4.7% increase in its shares to hit a day's high of $204.20 apiece on March 19, following the release of its second quarter earnings for fiscal 2026.

Key Highlights

  • Revenue in US dollar terms increased by 8% to $18.04 billion, beating estimates of $17.84 billion.
  • Operating income for the quarter rose by 11% to $2.49 billion.
  • Operating margin expanded to 13.8%.
  • Adjusted earnings per share stood at $2.93, higher than $2.82 in the same period last year.
  • Net income was $1.86 billion, compared to $1.82 billion in the second quarter of fiscal 2025.
  • New bookings for the second quarter of fiscal 2026 stood at $22.11 billion, a 6% increase in US dollar terms and a 1% increase in local currency.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Guidance and Outlook

  • Accenture forecasts full-year revenue growth to be 3% to 5% in local currency.
  • Excluding an estimated 1% impact from its US federal business, the company expects revenue growth to be 4% to 6% in local currency.
  • Full-year GAAP diluted earnings per share are expected to be in the range of $13.25 to $13.50, a 9% to 11% increase.
  • Full-year adjusted earnings per share are expected to be in the range of $13.65 to $13.90, a 6% to 8% increase.
  • The company has lifted its full-year free cash flow expectation to be in the range of $10.8 billion to $11.5 billion.

Investor Takeaway

Investors should consider Accenture's strong second-quarter earnings and growing AI demand as a positive indicator for the company's future performance.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.